Cargando…

Fluid management: the pharmacoeconomic dimension

Cost is a key concern in fluid management. Relatively few data are available that address the comparative total costs of care between different fluid management regimens in particular clinical indications. Relevant costs of fluid-associated morbidity and mortality, including those incurred after int...

Descripción completa

Detalles Bibliográficos
Autor principal: Vincent, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226174/
https://www.ncbi.nlm.nih.gov/pubmed/11255597
http://dx.doi.org/10.1186/cc969
_version_ 1782217575337295872
author Vincent, Jean-Louis
author_facet Vincent, Jean-Louis
author_sort Vincent, Jean-Louis
collection PubMed
description Cost is a key concern in fluid management. Relatively few data are available that address the comparative total costs of care between different fluid management regimens in particular clinical indications. Relevant costs of fluid-associated morbidity and mortality, including those incurred after intensive care unit or hospital discharge, also need to be considered in evaluating the cost-benefit ratios of administered fluids. Rigorously designed pharmacoeconomic studies are needed to delineate the costs and benefits of various approaches to fluid management.
format Online
Article
Text
id pubmed-3226174
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32261742011-11-30 Fluid management: the pharmacoeconomic dimension Vincent, Jean-Louis Crit Care Proceedings Cost is a key concern in fluid management. Relatively few data are available that address the comparative total costs of care between different fluid management regimens in particular clinical indications. Relevant costs of fluid-associated morbidity and mortality, including those incurred after intensive care unit or hospital discharge, also need to be considered in evaluating the cost-benefit ratios of administered fluids. Rigorously designed pharmacoeconomic studies are needed to delineate the costs and benefits of various approaches to fluid management. BioMed Central 2000 2000-10-13 /pmc/articles/PMC3226174/ /pubmed/11255597 http://dx.doi.org/10.1186/cc969 Text en Copyright ©2000 Current Science Ltd
spellingShingle Proceedings
Vincent, Jean-Louis
Fluid management: the pharmacoeconomic dimension
title Fluid management: the pharmacoeconomic dimension
title_full Fluid management: the pharmacoeconomic dimension
title_fullStr Fluid management: the pharmacoeconomic dimension
title_full_unstemmed Fluid management: the pharmacoeconomic dimension
title_short Fluid management: the pharmacoeconomic dimension
title_sort fluid management: the pharmacoeconomic dimension
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226174/
https://www.ncbi.nlm.nih.gov/pubmed/11255597
http://dx.doi.org/10.1186/cc969
work_keys_str_mv AT vincentjeanlouis fluidmanagementthepharmacoeconomicdimension